Investigation of Fiber-Matrix Interface Strength via Single-Fiber Pull-Out Test in 3D-Printed Thermoset Composites: A Simplified Methodology.

The emergence of additive manufacturing technologies for fiber-reinforced thermoset composites has greatly bolstered their utilization, particularly within the aerospace industry. However, the ability to precisely measure the interface strength between the fiber and thermoset matrix in additively manufactured composites has been constrained by the cumbersome nature of single-fiber pull-out experiments and the need for costly instrumentation. This study aims to introduce a novel methodology for conducting single-fiber pull-out tests aimed at quantifying interface shear strength in additively manufactured thermoset composites.

Comparative effects on dynamic renal potassium excretion of ACE inhibition versus angiotensin receptor blockade in hypertensive patients with type II diabetes mellitus.

Both ACE inhibitors (ACEI) and angiotensin receptor blockers (ARB) are renoprotective beyond their effects on blood pressure (BP), but their widespread use is limited by their tendency to provoke hyperkalemia. The comparative effects of ACEI and ARB on potassium handling have not been investigated. The objective of this study was to determine whether there are differences in dynamic renal potassium handling between ACEI and ARB in response to an oral potassium challenge.

Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor.

Objectives: The molecular mechanisms whereby severe, uncontrolled hypertension (SHT) is translated into acute vascular target organ dysfunction have not been completely defined. We sought to determine whether SHT is associated with pressure-dependent endothelial activation as assessed by soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1 (sICAM-1) and von Willebrand Factor (vWF).

Methods: We determined sVCAM-1, sICAM-1 and vWF in three groups: (i) untreated patients referred specifically for treatment of SHT [diastolic blood pressure (DBP) > or = 120 mm Hg; n = 24]; (ii) untreated patients with established mild hypertension (MHT; DBP 95-100 mmHg; n = 19); and (iii) normotensive volunteers (DBP < or = 90; n = 16).